Doo Ho Choi

Sungkyunkwan University, Samsung Medical Center

Papers

3

Total Citations

47

H-Index

3

About

Doo Ho Choi is a leading figure in radiation oncology, with key research spanning preoperative chemoradiotherapy for rectal cancer and advanced quality assurance in proton therapy. His most impactful work, a phase II multi-institutional clinical trial (KROG 11-02), demonstrated the efficacy of a two-week course of preoperative chemoradiotherapy followed by delayed surgery for rectal cancer, earning 25 citations and shaping treatment protocols. In proton therapy, Choi has made significant contributions to safety and precision, including developing a virtual simulator to predict and prevent patient-nozzle collisions—a critical innovation given the large nozzle structures and minimal air gaps in proton delivery. This work, cited 10 times, enhances treatment accuracy and patient safety. Additionally, his high-precision quality assurance methods for robotic couches with six degrees of freedom (12 citations) ensure reliable patient positioning. Through these contributions, Choi has advanced both clinical outcomes and technological safety in radiation oncology, establishing himself as a key innovator in the field.

Research Focus

Key Achievements

3
H-Index
3
Papers
47
Total Citations
16
Avg Citations/Paper
🏆 Most Cited Paper
Two-week course of preoperative chemoradiotherapy followed by delayed surgery for rectal cancer: A phase II multi-institutional clinical trial (KROG 11-02)
25 citations · 2014
📈 Most Prolific Year: 2014 (1 Papers)
🤝 Key Collaborators: 23
🏛 Institutions: Sungkyunkwan University, Samsung Medical Center

Top Papers

  1. 1
  2. 2
  3. 3

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago